Abstract
During the COVID-19 pandemic, the introduction of non-pharmaceutical interventions (NPIs) resulted in an unprecedented reduction in the transmission of the respiratory syncytial virus (RSV), the predominant cause of bronchiolitis. As NPIs were eased, it was speculated that RSV transmission would return with an increase in the severity of bronchiolitis. In a large tertiary hospital, a dramatic reduction in the incidence of bronchiolitis was seen during the COVID-19 pandemic. The easing of NPIs correlated with an increase in RSV transmission particularly in the community; however, there was no evidence of an increase in the severity of bronchiolitis.
Reference6 articles.
1. RSV bronchiolitis season 2021 has arrived, so be prepared! arch DIS child;Hussain;Arch Dis Child,2021
2. Morgan E . Written statement: paediatric respiratory syncytial virus [Internet]. Welsh Government; 2021. Available: https://www.gov.wales/written-statement-paediatric-respiratory-syncytial-virus
3. Australian RSV study group. Off-season RSV epidemics in Australia after easing of COVID-19 restrictions;Eden;Nat Commun,2022
4. Public Health Wales . Weekly influenza and acute respiratory infection surveillance report. 2023. Available: https://phw.nhs.wales/topics/immunisation-and-vaccines/fluvaccine/weekly-influenza-and-acute-respiratory-infection-report/october-2022-october-2023-flu-season-202223/phw-influenza-surveillance-report-for-2023-week-23pdf/ [Accessed 18 Apr 2023].
5. Parental hesitancy and concerns around accessing paediatric unscheduled healthcare during COVID-19: a cross-sectional survey;Nicholson;Int J Environ Res Public Health,2020